New clinical trial results bode well for what could be the first GLP-1 weight loss drug taken as a pill, not by injection. The daily pill, orforglipron, is currently under investigation by drugmaker Eli Lilly, which funded the study. In the 18-month trial, people with type 2 diabetes and obesity who took the highest (36… read on > read on >










.jpeg)




-300x211.jpeg)








